Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Pia Banerjee

Pia Banerjee

Life Sciences


Ms. Banerjee joined Bain Capital Life Sciences in 2017. Prior to joining Bain Capital Life Sciences, Ms. Banerjee spent several years in various healthcare investment banking roles. She joined Moelis & Co. in 2015, where she contributed to building a new M&A practice dedicated to large and small pharma/biotech clients. Prior to Moelis, she worked at Leerink Partners where she was involved with numerous biotechnology IPOs as well as specialty pharma M&A transactions. She began her career at Houlihan Lokey where she focused on valuation for life sciences companies.


Ms. Banerjee graduated summa cum laude from the Vagelos Program in Life Sciences and Management at the University of Pennsylvania. She received a BA in Biology from Penn and a BS in Finance from The Wharton School.